What Was Randomized in a Survey Comparing Intense Drug Experiences?
The experience being reported was selected through survey-routing procedures. The substance exposure itself was not randomly assigned. That distinction determines what a retrospective comparison can establish.
Routing participants to past experiences
Chwyl and colleagues’ supplied preprint analyzed 397 adults reporting on intense psilocybin, MDMA or cannabis experiences within the previous five years. Recruitment used general advertisements on a crowdsourcing platform.
The researchers initially randomized screening-question order and later used adaptive routing to obtain approximately balanced reporting groups. As conditions filled, they were removed from the routing scheme; the final 47 participants were routed exclusively to the MDMA survey.
These procedures concerned who answered which survey about an experience that had already happened. They did not determine which drug a participant previously used, the dose, the setting or the other substances taken.
Covariate adjustment answers another question
The analyses compared mystical and self-transcendent experience ratings and examined associations with contextual variables. Several substance-related differences became smaller after adjustment, while mindset variables were strongly associated with the reported outcomes.
Adjustment can describe how an association changes when measured covariates enter a model. It does not recreate random assignment of exposure or establish that a mindset variable caused the experience. Recall, selection into use and concurrent substance use remain relevant to interpretation.
What this design supports
The study describes relationships among remembered experiences in a community sample. Its routing scheme does not make it a controlled comparison of administering three drugs or a clinical treatment trial. A claim about drug effects should retain that distinction even when a methods section uses the word randomized.
Source
Chwyl C, Spata A, Lucas W, Luoma JB. Mindset Over Molecule: Comparing Self-Transcendent and Mystical Experiences Across Recreational Psilocybin, MDMA, and Cannabis Use. Supplied preprint, September 12, 2025. DOI 10.21203/rs.3.rs-7266162/v1.



